Cargando…

Cost-effectiveness of Fibrinogen Concentrate vs Cryoprecipitate for Treating Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients

IMPORTANCE: Excessive bleeding requiring fibrinogen replacement is a serious complication of cardiac surgery. However, the relative cost-effectiveness of the 2 available therapies—fibrinogen concentrate and cryoprecipitate—is unknown. OBJECTIVE: To determine cost-effectiveness of fibrinogen concentr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abrahamyan, Lusine, Tomlinson, George, Callum, Jeannie, Carcone, Steven, Grewal, Deep, Bartoszko, Justyna, Krahn, Murray, Karkouti, Keyvan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857805/ https://www.ncbi.nlm.nih.gov/pubmed/36598773 http://dx.doi.org/10.1001/jamasurg.2022.6818

Ejemplares similares

Weight-adjusted dosing of fibrinogen concentrate and cryoprecipitate in the treatment of hypofibrinogenaemic bleeding adult cardiac surgical patients: a post hoc analysis of the Fibrinogen Replenishment in cardiac surgery randomised controlled trial
por: Devine, Cian, et al.
Publicado: (2022)

Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial
por: Karkouti, Keyvan, et al.
Publicado: (2018)

The association of prothrombin complex concentrates with postoperative outcomes in cardiac surgery: an observational substudy of the FIBRES randomized controlled trial
por: Bartoszko, Justyna, et al.
Publicado: (2021)

Comparison of 4-Factor Prothrombin Complex Concentrate With Frozen Plasma for Management of Hemorrhage During and After Cardiac Surgery: A Randomized Pilot Trial
por: Karkouti, Keyvan, et al.
Publicado: (2021)

Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate
por: Collins, P. W., et al.
Publicado: (2014)

Randomized comparison of fibrinogen concentrate versus cryoprecipitate for bleeding control in pediatric cardiac surgery (FICCS study)
por: Galas, F, et al.
Publicado: (2012)

Acquired hypofibrinogenemia: current perspectives
por: Besser, Martin W, et al.
Publicado: (2016)

Fibrinogen storage disease without hypofibrinogenemia associated with estrogen therapy
por: Simsek, Z, et al.
Publicado: (2005)

Loss of Fibrinogen in Zebrafish Results in Symptoms Consistent with Human Hypofibrinogenemia
por: Vo, Andy H., et al.
Publicado: (2013)

Hepatic fibrinogen storage disease and hypofibrinogenemia caused by fibrinogen Aguadilla mutation: a case report
por: Gu, Leilei, et al.
Publicado: (2020)

Comparison of Bacterial Risk in Cryo AHF and Pathogen Reduced Cryoprecipitated Fibrinogen Complex
por: Lu, Thea, et al.
Publicado: (2022)

Differences in coagulation-relevant parameters: Comparing cryoprecipitate and a human fibrinogen concentrate
por: Stanford, Sophia, et al.
Publicado: (2023)

IMPACT OF THE INTRAOPERATIVE USE OF FIBRINOGEN CONCENTRATE FOR HYPOFIBRINOGENEMIA DURING THORACIC AORTIC SURGERY
por: ARAKI, YOSHIMORI, et al.
Publicado: (2015)

The Efficacy of Fibrinogen Concentrates in Relation to Cryoprecipitate in Restoring Clot Integrity and Stability against Lysis
por: Whyte, Claire S., et al.
Publicado: (2022)

Cryoprecipitate therapy
por: Nascimento, B., et al.
Publicado: (2014)

Nonsurgical management of major hemorrhage
por: Callum, Jeannie, et al.
Publicado: (2023)

Prise en charge non chirurgicale de l’hémorragie majeure
por: Callum, Jeannie, et al.
Publicado: (2023)

Raising the bar on fibrinogen: a retrospective assessment of critical hypofibrinogenemia in severely injured trauma patients
por: Richards, Justin, et al.
Publicado: (2023)

A novel fibrinogen γ-chain frameshift mutation, p. Cys365Phefs*41, causing hypofibrinogenemia with bleeding phenotype in a Chinese family
por: Zhou, Weijie, et al.
Publicado: (2021)

Protocol for a multicentre, randomised, parallel-control, superiority trial comparing administration of clotting factor concentrates with a standard massive haemorrhage protocol in severely bleeding trauma patients: the FiiRST 2 trial (a 2020 EAST multicentre trial)
por: da Luz, Luis Teodoro, et al.
Publicado: (2021)

Early administration of fibrinogen concentrate in patients with polytrauma with thromboelastometry suggestive of hypofibrinogenemia: A randomized feasibility trial
por: de Lucena, Lucas Siqueira, et al.
Publicado: (2021)

Hypofibrinogenemia and miscarriage: report of a first successful pregnancy under fibrinogen substitution and short review of the literature
por: Sucker, Christoph, et al.
Publicado: (2022)

A Novel Nonsense Mutation in FGB (c.1421G>A; p.Trp474Ter) in the Beta Chain of Fibrinogen Causing Hypofibrinogenemia with Bleeding Phenotype
por: Simurda, Tomas, et al.
Publicado: (2020)

Factors affecting the quality of cryoprecipitate
por: Subramaniyan, Rajeswari, et al.
Publicado: (2017)

Perioperative Cryoprecipitate Waste Reduction
por: Burk, Camden, et al.
Publicado: (2021)

Use of Cryoprecipitate in Newborn Infants
por: Tyagi, Manvi, et al.
Publicado: (2023)

A Novel Amino Acid Substitution, Fibrinogen Bβp.Pro234Leu, Associated with Hypofibrinogenemia Causing Impairment of Fibrinogen Assembly and Secretion
por: Kaido, Takahiro, et al.
Publicado: (2020)

Effect of cryoprecipitate on an increase in fibrinogen level in patients with excessive intraoperative blood loss: a single-center retrospective study
por: Kouroki, Satoshi, et al.
Publicado: (2022)

Comparison of coagulation parameters associated with fibrinogen concentrate and cryoprecipitate for treatment of bleeding in patients undergoing cytoreductive surgery for pseudomyxoma peritonei: Subanalysis from a randomized, controlled phase 2 study
por: Roy, Ashok, et al.
Publicado: (2023)

Cryoprecipitate as an alternative to platelet transfusion in thrombocytopenia
por: Crispin, Philip, et al.
Publicado: (2021)

Transient hypofibrinogenemia due to allopurinol
por: Yin, ZhiQiang, et al.
Publicado: (2014)

Hereditary Hypofibrinogenemia with Hepatic Storage
por: Asselta, Rosanna, et al.
Publicado: (2020)

Heterogeneity of Genotype–Phenotype in Congenital Hypofibrinogenemia—A Review of Case Reports Associated with Bleeding and Thrombosis
por: Brunclikova, Monika, et al.
Publicado: (2022)

Initial Results of Empirical Cryoprecipitate Transfusion in the Treatment of Isolated Severe Traumatic Brain Injury: Use of In-house-produced Cryoprecipitate
por: SHIBAHASHI, Keita, et al.
Publicado: (2019)

A Randomized Pilot Trial Assessing the Role of Human Fibrinogen Concentrate in Decreasing Cryoprecipitate Use and Blood Loss in Infants Undergoing Cardiopulmonary Bypass
por: Tirotta, Christopher F., et al.
Publicado: (2022)

Risk factors and clinical outcomes associated with acquired hypofibrinogenemia in patients administered hemocoagulase batroxobin for hemoptysis
por: Lee, Jae-Kyeong, et al.
Publicado: (2022)

Risk Factors for Tigecycline-Associated Hypofibrinogenemia
por: Liu, Jia, et al.
Publicado: (2021)

Recombinant γY278H Fibrinogen Showed Normal Secretion from CHO Cells, but a Corresponding Heterozygous Patient Showed Hypofibrinogenemia
por: Kamijo, Tomu, et al.
Publicado: (2021)

Variability in response to cryoprecipitate treatment for hemostatic defects in uremia.
por: Triulzi, D. J., et al.
Publicado: (1990)

Total knee arthroplasty in a patient with hypofibrinogenemia
por: Nacca, Christopher R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4abnu2bmhlkv9iofdec4t1srtl